192 related articles for article (PubMed ID: 28675505)
1. Supramolecular interactions between β-lapachone with cyclodextrins studied using isothermal titration calorimetry and molecular modeling.
Xavier-Junior FH; Rabello MM; Hernandes MZ; Dias MES; Andrada OHMS; Bezerra BP; Ayala AP; Santos-Magalhães NS
J Mol Recognit; 2017 Nov; 30(11):. PubMed ID: 28675505
[TBL] [Abstract][Full Text] [Related]
2. Elucidation of the complexation mechanism between (+)-usnic acid and cyclodextrins studied by isothermal titration calorimetry and phase-solubility diagram experiments.
Segura-Sanchez F; Bouchemal K; Lebas G; Vauthier C; Santos-Magalhaes NS; Ponchel G
J Mol Recognit; 2009; 22(3):232-41. PubMed ID: 19153981
[TBL] [Abstract][Full Text] [Related]
3. Fexofenadine/cyclodextrin inclusion complexation: phase solubility, thermodynamic, physicochemical, and computational analysis.
Omari MM; Badwan AA; Zughul MB; Eric J; Davies D
Drug Dev Ind Pharm; 2007 Nov; 33(11):1205-15. PubMed ID: 18058317
[TBL] [Abstract][Full Text] [Related]
4. Dramatic improvement of the solubility of pseudolaric acid B by cyclodextrin complexation: preparation, characterization and validation.
Chi L; Liu R; Guo T; Wang M; Liao Z; Wu L; Li H; Wu D; Zhang J
Int J Pharm; 2015 Feb; 479(2):349-56. PubMed ID: 25575474
[TBL] [Abstract][Full Text] [Related]
5. The encapsulation of β-lapachone in 2-hydroxypropyl-β-cyclodextrin inclusion complex into liposomes: a physicochemical evaluation and molecular modeling approach.
Cavalcanti IM; Mendonça EA; Lira MC; Honrato SB; Camara CA; Amorim RV; Mendes Filho J; Rabello MM; Hernandes MZ; Ayala AP; Santos-Magalhães NS
Eur J Pharm Sci; 2011 Oct; 44(3):332-40. PubMed ID: 21888967
[TBL] [Abstract][Full Text] [Related]
6. Solubility Enhancement of Myricetin by Inclusion Complexation with Heptakis-
Han D; Han Z; Liu L; Wang Y; Xin S; Zhang H; Yu Z
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31991574
[TBL] [Abstract][Full Text] [Related]
7. Elucidation of the orientation of selected drugs with 2-hydroxylpropyl-β-cyclodextrin using 2D-NMR spectroscopy and molecular modeling.
Adhikari S; Daftardar S; Fratev F; Rivera M; Sirimulla S; Alexander K; Boddu SHS
Int J Pharm; 2018 Jul; 545(1-2):357-365. PubMed ID: 29747001
[TBL] [Abstract][Full Text] [Related]
8. Encapsulation of Risperidone by Methylated β-Cyclodextrins: Physicochemical and Molecular Modeling Studies.
Sbârcea L; Tănase IM; Ledeți A; Cîrcioban D; Vlase G; Barvinschi P; Miclău M; Văruţ RM; Trandafirescu C; Ledeți I
Molecules; 2020 Dec; 25(23):. PubMed ID: 33287127
[TBL] [Abstract][Full Text] [Related]
9. Complexation of triptolide and its succinate derivative with cyclodextrins: affinity capillary electrophoresis, isothermal titration calorimetry and 1H NMR studies.
Danel C; Duval C; Azaroual N; Vaccher C; Bonte JP; Bailly C; Landy D; Goossens JF
J Chromatogr A; 2011 Dec; 1218(48):8708-14. PubMed ID: 22033106
[TBL] [Abstract][Full Text] [Related]
10. A supramolecular complex between proteinases and beta-cyclodextrin that preserves enzymatic activity: physicochemical characterization.
Denadai AM; Santoro MM; Lopes MT; Chenna A; de Sousa FB; Avelar GM; Gomes MR; Guzman F; Salas CE; Sinisterra RD
BioDrugs; 2006; 20(5):283-91. PubMed ID: 17025375
[TBL] [Abstract][Full Text] [Related]
11. Physicochemical characterisation of the supramolecular structure of luteolin/cyclodextrin inclusion complex.
Liu B; Li W; Zhao J; Liu Y; Zhu X; Liang G
Food Chem; 2013 Nov; 141(2):900-6. PubMed ID: 23790865
[TBL] [Abstract][Full Text] [Related]
12. Modulating beta-lapachone release from polymer millirods through cyclodextrin complexation.
Wang F; Blanco E; Ai H; Boothman DA; Gao J
J Pharm Sci; 2006 Oct; 95(10):2309-19. PubMed ID: 16883563
[TBL] [Abstract][Full Text] [Related]
13. Effects of the Preparation Method on the Formation of True Nimodipine SBE-β-CD/HP-β-CD Inclusion Complexes and Their Dissolution Rates Enhancement.
Semcheddine F; Guissi Nel I; Liu X; Wu Z; Wang B
AAPS PharmSciTech; 2015 Jun; 16(3):704-15. PubMed ID: 25511809
[TBL] [Abstract][Full Text] [Related]
14. Sildenafil/cyclodextrin complexation: stability constants, thermodynamics, and guest-host interactions probed by 1H NMR and molecular modeling studies.
Al Omari MM; Zughul MB; Davies JE; Badwan AA
J Pharm Biomed Anal; 2006 Jun; 41(3):857-65. PubMed ID: 16527440
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of oral bioavailability of cilostazol by forming its inclusion complexes.
Patel SG; Rajput SJ
AAPS PharmSciTech; 2009; 10(2):660-9. PubMed ID: 19459053
[TBL] [Abstract][Full Text] [Related]
16. Characterization of beta-lapachone and methylated beta-cyclodextrin solid-state systems.
Cunha-Filho MS; Dacunha-Marinho B; Torres-Labandeira JJ; Martínez-Pacheco R; Landín M
AAPS PharmSciTech; 2007 Jul; 8(3):E60. PubMed ID: 17915810
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of solubility and bioavailability of beta-lapachone using cyclodextrin inclusion complexes.
Nasongkla N; Wiedmann AF; Bruening A; Beman M; Ray D; Bornmann WG; Boothman DA; Gao J
Pharm Res; 2003 Oct; 20(10):1626-33. PubMed ID: 14620518
[TBL] [Abstract][Full Text] [Related]
18. Release Characteristics of an Essential Oil Component Encapsulated with Cyclodextrin Shell Matrices.
Li Z; Wen W; Chen X; Zhu L; Cheng G; Liao Z; Huang H; Ming L
Curr Drug Deliv; 2021; 18(4):487-499. PubMed ID: 32735520
[TBL] [Abstract][Full Text] [Related]
19. Cyclodextrins: Efficient biocompatible solubilizing excipients for bromhexine liquid and semi-solid drug delivery systems.
Stojanov M; Nielsen HM; Larsen KL
Int J Pharm; 2012 Jan; 422(1-2):349-55. PubMed ID: 22027391
[TBL] [Abstract][Full Text] [Related]
20. Inclusion Complexation of Etodolac with Hydroxypropyl-beta-cyclodextrin and Auxiliary Agents: Formulation Characterization and Molecular Modeling Studies.
Sherje AP; Kulkarni V; Murahari M; Nayak UY; Bhat P; Suvarna V; Dravyakar B
Mol Pharm; 2017 Apr; 14(4):1231-1242. PubMed ID: 28248111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
